NCT00862472View on ClinicalTrials.gov

Safety and Efficacy Study of DuoTrav APS Versus DuoTrav

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

DuoTrav APS

DuoTrav APS QD AM

DRUG

DuoTrav

DuoTrav QD AM

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00862472 - Safety and Efficacy Study of DuoTrav APS Versus DuoTrav | Biotech Hunter | Biotech Hunter